|
Market Closed -
Other stock markets
|
After hours 19:56:13 | |||
| 4.730 USD | -3.47% |
|
4.665 | -1.37% |
| Market Cap | 2.49B 2.15B 1.98B 1.86B 3.48B 237B 3.53B 23.41B 9.13B 115B 9.35B 9.15B 399B | P/E Ratio 2026 * |
360x | P/E Ratio 2027 * | 367x |
|---|---|---|---|---|---|
| Enterprise Value | 2.33B 2.01B 1.86B 1.74B 3.26B 222B 3.31B 21.91B 8.54B 108B 8.75B 8.56B 374B | EV / Sales 2026 * |
0.8x | EV / Sales 2027 * | 0.7x |
| Free-Float |
73.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Clover Health Investments, Corp.
| 1 day | -3.47% | ||
| 1 week | +23.50% | ||
| Current month | +18.84% | ||
| 1 month | +44.21% | ||
| 3 months | +140.10% | ||
| 6 months | +75.19% | ||
| Current year | +101.28% |
| 1 week | 3.81 |  | 5.18 |
| 1 month | 3.28 | | 5.18 |
| Current year | 1.58 | | 5.18 |
| 1 year | 1.58 | | 5.18 |
| 3 years | 0.61 | | 5.18 |
| 5 years | 0.61 | | 16.05 |
| 10 years | 0.61 | | 28.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Toy
CEO | Chief Executive Officer | 47 | 2022-12-31 |
Clay Thornton
DFI | Director of Finance/CFO | 36 | 2026-03-29 |
Shelly Gupta
CTO | Chief Tech/Sci/R&D Officer | - | 2025-04-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Vivek Garipalli
CHM | Chairman | 47 | 2022-12-31 |
Thomas Tran
BRD | Director/Board Member | 69 | 2024-08-19 |
William Robinson
BRD | Director/Board Member | 61 | 2021-03-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Sell | Executive/Senior Manager | -7,289 | 0.0017% | ||
| 05-27 | Sell | Chief Technology Officer | -220,426 | 0.0514% | ||
| 05-17 | Sell | Director | -67,160 | 0.0157% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.47% | +23.50% | +61.43% | +395.18% | 2.49B | |
| +0.73% | +2.27% | +28.26% | -17.07% | 371B | |
| +1.23% | -2.76% | +4.62% | -14.55% | 87.75B | |
| +1.07% | +2.94% | -5.51% | +11.61% | 78.83B | |
| +2.86% | +8.32% | +61.40% | -26.11% | 45.53B | |
| +2.60% | +4.59% | +17.71% | -5.77% | 32.19B | |
| +3.66% | +4.94% | -31.76% | -30.62% | 10.43B | |
| -2.42% | +28.50% | +30.97% | +166.17% | 4.08B | |
| +3.82% | +2.98% | +23.57% | -32.58% | 2.09B | |
| +7.52% | +4.41% | -24.94% | - | 293M | |
| Average | +1.70% | +8.20% | +16.58% | +49.59% | 63.47B | |
| Weighted average by Cap. | +0.73% | +2.52% | +21.76% | -10.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.91B 2.51B 2.32B 2.17B 4.06B 277B 4.13B 27.35B 10.66B 135B 10.92B 10.69B 466B | 3.32B 2.87B 2.64B 2.48B 4.64B 316B 4.71B 31.23B 12.18B 154B 12.47B 12.21B 532B |
| Net income | 6.42M 5.55M 5.11M 4.78M 8.97M 610M 9.1M 60.35M 23.53M 297M 24.1M 23.59M 1.03B | 7.96M 6.87M 6.33M 5.93M 11.11M 756M 11.28M 74.78M 29.15M 368M 29.86M 29.23M 1.27B |
| Net Debt | -160M -138M -127M -119M -223M -15.17B -226M -1.5B -585M -7.38B -599M -586M -25.56B | -151M -131M -120M -113M -211M -14.38B -214M -1.42B -554M -7B -568M -556M -24.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 4.730 $ | -3.47% | 10,502,493 |
| 26-06-11 | 4.900 $ | +0.20% | 16,891,260 |
| 26-06-10 | 4.890 $ | +13.99% | 26,265,037 |
| 26-06-09 | 4.290 $ | +9.44% | 15,054,216 |
| 26-06-08 | 3.920 $ | +2.35% | 4,179,487 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLOV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition